dc.contributor | Guerra, Pablo Antonio | |
dc.contributor | Buitrago-Medina, Daniel-Alejandro | |
dc.contributor | Trillos, Marcial | |
dc.contributor | Lombo, Miguel | |
dc.contributor | Galindo, Patricia | |
dc.contributor | Pulido, Felipe | |
dc.creator | Cubides Nuñez, Ricardo Alonso | |
dc.date.accessioned | 2020-07-29T22:21:03Z | |
dc.date.accessioned | 2022-09-22T14:35:14Z | |
dc.date.available | 2020-07-29T22:21:03Z | |
dc.date.available | 2022-09-22T14:35:14Z | |
dc.date.created | 2020-07-29T22:21:03Z | |
dc.identifier | https://repository.urosario.edu.co/handle/10336/25571 | |
dc.identifier | https://doi.org/10.48713/10336_25571 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/3440256 | |
dc.description.abstract | Introduction: Aortic valve pathology is the valvular disease with the highest rate of surgical management. Its treatment is constantly evolving. Surgical aortic valve replacement (SARV) is still the standard of care, however transcatheter aortic valve implantation (TAVI) represents a valuable alternative in patients with high surgical risk. Knowing our population and its characteristics gives us a better understanding of this disease in our society. Methodology: A retrospective, cross sectional, descriptive study was performed, it describes sociodemographic, clinical and surgical variables and the prevalence of outcomes and postoperative complications in patients with diagnosis of aortical stenosis and aortical insufficiency between 2015 and 2018, who were surgically intervened. Results: Information from 163 patients was collected during the study, 138 patients were managed with SAVR and 25 with TAVI. The most frequent valvular pathology was aortic stenosis 74.8%. The most frequent comorbidity was hypertension 70.5%, followed by COPD 23.9%, smoking 19.6% and obesity 12.7%. The most frequent symptom was dyspnoea and chest pain. 39.6% of patients had any grade of preoperative left ventricular ejection fraction (LVEF) reduction with postoperative improvement in 41%. The average Euro Score II was 4.16%. Global morbidity and mortality was 44% and 9.2% respectively. Conclusion: Clinical and demographical characteristics of the population along with their outcomes are similar to international medical literature reports, nevertheless some aspects intrinsic to the population can influence patient outcomes. | |
dc.language | spa | |
dc.publisher | Universidad del Rosario | |
dc.publisher | Especialización en Cirugía General | |
dc.publisher | Facultad de Medicina | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights | Abierto (Texto Completo) | |
dc.rights | EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma.
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización.
--------------------------------------
POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos. | |
dc.source | 1. Bonow R, Carabello B, de Leon A, Edmunds L, Fedderly B, Freed M et al. Guidelines for the Management of Patients With Valvular Heart Disease. Circulation. 1998;98(18):1949-1984.
| |
dc.source | 2. Horstkotte D. Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary The Task Force on Infective Endocarditis of the European Society of Cardiology. European Heart Journal. 2004;25(3):267-276. | |
dc.source | 3. Ramlawi B, Bedeir K, Lamelas J. Aortic Valve Surgery: Minimally Invasive Options. Methodist DeBakey Cardiovascular Journal. 2016;12(1):27-32 | |
dc.source | 4. Melnitchouk S, Dal-Bianco J, Borger M. Minimally Invasive Mitral Valve Surgery via Mini-Thoracotomy: Current Update. Current Treatment Options in Cardiovascular Medicine. 2015;17(11) | |
dc.source | 5. Ferreira R, Silva R, Marchi E. Aortic Valve Replacement: Treatment by Sternotomy versus Minimally Invasive Approach. Brazilian Journal of Cardiovascular Surgery. 2016 | |
dc.source | 6. Ji Hyun Bang. M:D. Et. Al, Minimally Invasive Approaches Versus Conventional Sternotomy For Aortic Valve Replacement: A Propensity Score Matching Study, Korean J Thorac Cardiovasc Surg 2012;45:80-84 | |
dc.source | 7. Bang J, Kim J, Lee J, Kim J, Jung S, Choo S et al. Minimally Invasive Approaches Versus Conventional Sternotomy for Aortic Valve Replacement: A Propensity Score Matching Study. The Korean Journal of Thoracic and Cardiovascular Surgery. 2012;45(2):80-84. | |
dc.source | 8. Alison F, Eugene A, Aubrey C, Minimally Invasive Mitral Surgery Through Right Mini-Thoracotomy Under Direct Vision J Thorac Dis 2013;5(S6):S673-S679 | |
dc.source | 9. Miceli A, Murzi M, Canarutto D, Gilmanov D, Ferrarini M, Farneti Pa, Solinas M, Glauber M. Minimally Invasive Mitral Valve Repair Through Right Minithoracotomy In The Setting Of Degenerative Mitral Regurgitation: Early Outcomes And Long-Term Follow-Up. Ann Cardiothorac Surg 2015;4(5):422-427 | |
dc.source | 10. Sakaguchi T. Minimally invasive mitral valve surgery through a right mini-thoracotomy. General Thoracic and Cardiovascular Surgery. 2016;64(12):699-706 | |
dc.source | 11. Elattar M, van Kesteren F, Wiegerinck E, Vanbavel E, Baan J, Cocchieri R et al. Automated CTA based measurements for planning support of minimally invasive aortic valve replacement surgery. Medical Engineering & Physics. 2017;39:123-128. | |
dc.source | 12. Glauber M, Ferrarini M, Miceli A. Minimally invasive aortic valve surgery: state of the art and future directions. Ann Cardiothorac Surg. 2015;4(1):26‐32. | |
dc.source | 13. InformedegestiónFundaciónClínicaShaio, 2016. | |
dc.source | 14. Ferreira R, Silva R, Marchi E. Aortic Valve Replacement: Treatment by Sternotomy versus Minimally Invasive Approach. Brazilian Journal of Cardiovascular Surgery. 2016. | |
dc.source | 15. Boti B, Hindori V, Schade E, Kougioumtzoglou A, Verbeek E, Driessen-Waaijer A et al. Minimal invasive aortic valve replacement: associations of radiological assessments with procedure complexity. Journal of Cardiothoracic Surgery. 2019;14(1). | |
dc.source | 16. Van Brabandt H, Neyt M, Hulstaert F. Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ. 2012;345(jul31 4):e4710-e4710. | |
dc.source | 17. Azpitarte J, María Alonso Á, García Gallego F, González Santos J, Paré C, Tello A. Guías de práctica clínica de la Sociedad Española de Cardiología en valvulopatías. Revista Española de Cardiología. 2000;53(9):1209-1278. | |
dc.source | 18. Gargiulo G, Sannino A, Capodanno D, Barbanti M, Buccheri S, Perrino C et al. Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement. Annals of Internal Medicine. 2016;165(5):334. | |
dc.source | 19. Siontis G, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. European Heart Journal. 2016;37(47):3503-3512. | |
dc.source | 20. Ando T, Takagi H, Grines C. Transfemoral, transapical and transcatheter aortic valve implantation and surgical aortic valve replacement: a meta-analysis of direct and adjusted indirect comparisons of early and mid-term deaths. Interactive CardioVascular and Thoracic Surgery. 2017;25(3):484-492. | |
dc.source | 21. Singh K, Carson K, Rashid M, Jayasinghe R, AlQahtani A, Dick A et al. Transcatheter Aortic Valve Implantation in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: A Systematic Review and Meta-Analysis. Heart, Lung and Circulation. 2018;27(2):227-234. | |
dc.source | 22. Mantha A, Juo Y, Morchi R, Ebrahimi R, Ziaeian B, Shemin R et al. Evolution of Surgical Aortic Valve Replacement in the Era of Transcatheter Valve Technology. JAMA Surgery. 2017;152(11):1080. | |
dc.source | 23. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739-2786 | |
dc.source | 24. Gleason T, Reardon M, Popma J, Deeb G, Yakubov S, Lee J et al. 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients. Journal of the American College of Cardiology. 2018;72(22):2687-2696. | |
dc.source | 25. Capodanno D, Petronio AS, Prendergast B, et al.Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2017;52:408–417. | |
dc.source | 26. Rodriguez-Gabella T, Voisine P, Dagenais F, Mohammadi S, Perron J, Dumont E et al. Long-Term Outcomes Following Surgical Aortic Bioprosthesis Implantation. Journal of the American College of Cardiology. 2018;71(13):1401-1412. | |
dc.source | 27. Douglas P, Leon M, Mack M, Svensson L, Webb J, Hahn R et al. Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial. JAMA Cardiology. 2017;2(11):1197. | |
dc.source | 28. Didier R, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P et al. Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients. FRANCE-2 registry. Circulation. 2018;138(23):2597-2607. | |
dc.source | 29. Asgar A. Transcatheter Aortic Valve Replacement and Valve Durability. Circulation. 2018;138(23):2608-2610. | |
dc.source | 30. Mack M, Leon M, Smith C, Miller D, Moses J, Tuzcu E et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. The Lancet. 2015;385(9986):2477-2484. | |
dc.source | 31. Nishimura R, Otto C, Bonow R, Carabello B, Erwin J, Fleisher L et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. Journal of the American College of Cardiology. 2017;70(2):252-289. | |
dc.source | 32. Martínez Ochoa C, Cañas E, Castro Pérez J, Saldarriaga Giraldo C, González Berrío C, González Jaramillo N. Valor predictivo del EuroSCORE II y el STS score en pacientes sometidos a cirugía cardiaca valvular por el abordaje mínimamente invasivo. Revista Colombiana de Cardiología. 2016;23(5):427-434. | |
dc.source | instname:Universidad del Rosario | |
dc.source | reponame:Repositorio Institucional EdocUR | |
dc.subject | Cirugía valvular aórtica | |
dc.subject | Cirugía mínimamente invasiva | |
dc.subject | Reemplazo valvular aórtico percutáneo | |
dc.title | Complicaciones en pacientes intervenidos por reemplazo valvular aórtico en el Hospital Universitario Mayor Mederi 2015 – 2018 | |
dc.type | masterThesis | |